About BIOVOX

BIOVOX GmbH is the trailblazer in the development of sustainable medical grade bioplastics. The company’s mission is to lead the way in providing high-quality, low-carbon and biocompatible materials for the healthcare industry, according to the VDI 2017 standard. BIOVOX’s innovative bioplastics can be used in a wide range of medical applications, offering a sustainable alternative to conventional plastics and ensuring patient safety.

Press releases

Press
25. September 2024

Traction for sustainable healthcare plastics – BIOVOX successfully closes €2.2 million seed round

BIOVOX, the pioneer of sustainable bioplastics for medical applications has closed its €2.2 million seed round led by HTGF. The company produces and supplies medically safe and sustainable plastics that meet current and future standards for the healthcare sector. BIOVOX’s bio-based plastics reduce the carbon footprint by 50 to 85% compared to conventional plastics and can be used in a wide range of medical applications. Darmstadt, Germany – 25 September 2024 – BIOVOX G
 

Info & Contact

Dr.-Ing. Julian Lotz, CEO BIOVOX GmbH
Web:
www.biovox.systems

Address

BIOVOX GmbH
Bunsenstraße 15
64293 Darmstadt
Germany

In portfolio

17. May 2024
 

Tilmann Petersen

Investment Manager